Yan, Y.; Hu, K.; Fu, M.; Deng, X.; Guan, X.; Luo, S.; Zhang, M.; Liu, Y.; Hu, Q.
CCL28 Enhances HSV-2 gB-Specific Th1-Polarized Immune Responses against Lethal Vaginal Challenge in Mice. Vaccines 2022, 10, 1291.
https://doi.org/10.3390/vaccines10081291
AMA Style
Yan Y, Hu K, Fu M, Deng X, Guan X, Luo S, Zhang M, Liu Y, Hu Q.
CCL28 Enhances HSV-2 gB-Specific Th1-Polarized Immune Responses against Lethal Vaginal Challenge in Mice. Vaccines. 2022; 10(8):1291.
https://doi.org/10.3390/vaccines10081291
Chicago/Turabian Style
Yan, Yan, Kai Hu, Ming Fu, Xu Deng, Xinmeng Guan, Sukun Luo, Mudan Zhang, Yalan Liu, and Qinxue Hu.
2022. "CCL28 Enhances HSV-2 gB-Specific Th1-Polarized Immune Responses against Lethal Vaginal Challenge in Mice" Vaccines 10, no. 8: 1291.
https://doi.org/10.3390/vaccines10081291
APA Style
Yan, Y., Hu, K., Fu, M., Deng, X., Guan, X., Luo, S., Zhang, M., Liu, Y., & Hu, Q.
(2022). CCL28 Enhances HSV-2 gB-Specific Th1-Polarized Immune Responses against Lethal Vaginal Challenge in Mice. Vaccines, 10(8), 1291.
https://doi.org/10.3390/vaccines10081291